Monthly Archives: April 2017

Sanofi and Lonza Partner to Build Biologics Production Facility in Switzerland

By | April 28, 2017

Lonza has announced that they will partner with Sanofi to build and operate a large-scale mammalian cell culture facility for monoclonal antibody production in Visp, Switzerland. The initial investment will be around CHF 290 million (€ 270 million), to be split equally between the companies. The initial phase of the facility will commence construction in… Read More »

Biogen Licenses Potential Alzheimer’s Drug from Bristol-Myers Squibb

By | April 28, 2017

Biogen has announced an agreement to exclusively license an experimental medicine with potential to treat Alzheimer’s disease (AD) and progressive supranuclear palsy (PSP) from Bristol-Myers Squibb. The drug, known as BMS-986168, is an antibody targeting extracellular tau, the protein that forms the deposits, or tangles, in the brain associated with AD and other neurodegenerative tauopathies… Read More »

Free Bioengineering Symposium at UNH on May 10

By | April 27, 2017

The 2017 University of New Hampshire Bioengineering Symposium on Wednesday, May 10 is a full-day event featuring several talks by invited speakers in key areas that are at the forefront of cutting-edge research worldwide and broadly represent the field of bioengineering. Topics include: Engineering Total Joint Replacements; In Vitro Models of Tissue Morphogenesis and Disease… Read More »

YPs Dish Up Good Conversation, Great Beer and Networking Bingo at Meadhall

By | April 26, 2017

The Young Professionals Spring Networking Event on April 6th at Meadhall in Cambridge was a big hit. This was the YPs first time holding an event at the popular Kendall Square bar and 37 young (and seasoned) professionals from a variety of local companies braved the torrential rain to enjoy Meadhall’s exquisite cuisine and wide… Read More »

EMD Serono Wins FDA Approval for Bavencio

By | April 20, 2017

The FDA has granted EMD Serono accelerated approval for Bavencio (avelumab), a drug for the treatment of metastatic Merkel cell carcinoma (MCC) a rare, aggressive form of skin cancer. This is the first FDA-approved treatment for metastatic MCC. “While skin cancer is one of the most common cancers, patients with a rare form called Merkel… Read More »

Paratek Announces Positive Results of Phase 3 Study of New Antibiotic

By | April 20, 2017

Paratek Pharmaceuticals has announced the second positive Phase 3 registration study of omadacycline, which will be used to support marketing applications to the FDA and EMA planned for 2018. The Phase 3 clinical study compares Paratek’s broad spectrum investigational antibiotic, omadacycline, to moxifloxacin in the treatment of patients with community-acquired bacterial pneumonia (CABP). “This successful… Read More »

ISA Food and Pharmaceutical Industry Division 4th Annual Symposium Arrives in Framingham May 16-17

By | April 10, 2017

Competitive forces, changing marketplace dynamics, and regulatory pressures are generating greater demand and need for new and more effective automation technologies in the pharmaceutical and food industries. More than ever before, manufacturing companies are seeking solutions and methodologies that increase quality, safety, reliability, profitability, cost control and production throughput. On May 16-17 at the Sheraton… Read More »